NCT01743638

Withdrawn

MR-Guided Laser Ablation of Prostate Bed Recurrences

Mayo Clinic Source

Compare

Other study identifiers

Sponsor study identifier

09-001584

Study Type

interventional

Actual enrollment (reported)

0

Locations

1 country

Sites

1

Timeline

Study Start

April 2012

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

February 2014

Actual (reported)

Study Completion

February 2014

Actual (reported)

Brief Summary

The purpose of this study is to see if MR-guided laser ablation can effectively treat prostate tumor recurrences.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: withdrawn
Actual enrollment (reported): 0 participants
Study completion date: February 2014
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
April 2012
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
December 4, 2012
Actual (reported)
First Posted
December 6, 2012
Actual (reported)
Primary Completion
February 2014
Actual (reported)
Study Completion
February 2014
Actual (reported)

Last Updated: April 10, 2014
Status Verified: April 2014
Last Update Submitted: April 9, 2014

Conditions

Prostate Tumors

Outcome Measures

Primary Outcomes (1)

Measurement of target lesion(s) dimensions at 3-6 month imaging follow-up
3-6 months

Study Arms (1)

MR-Guided Laser Ablation

EXPERIMENTAL

Procedure: MR-Guided Laser Ablation

Interventions

MR-Guided Laser AblationProcedure

MR-Guided Laser Ablation

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age50 Years - 95 Years

Sexmale

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Patients with "biopsy proven" soft tissue tumor recurrences of prostate fossa referred to Urology and/or Interventional Radiology for treatment.
Surgery is not a desirable alternative therapy at the time of enrollment

Sponsors & Collaborators

Mayo Clinic
Otherlead

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Officials

David A. Woodrum, M.D., Ph.D.
Mayo Clinic
PRINCIPAL INVESTIGATOR

Enrollment

0 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Assistant Professor of Radiology, Mayo Clinic

Study Record Dates

First Submitted

December 4, 2012

First Posted

December 6, 2012

Study Start

April 2012

Date type not reported

This date has not been verified as actual or estimated.

Radiation therapy has failed or not indicated or can be safely postponed

Tumor size ≤ 5 cm at its largest diameter

Tumor does not encompass the rectal wall or external urethral sphincter

Performance status is ECOG 2 or better in adults

Patient is able to undergo MRI

You may not qualify if:

Patients with pacemaker or defibrillator

Contact the study team to confirm eligibility.

Primary Completion

February 2014

Actual (reported)

Study Completion

February 2014

Actual (reported)

Last Updated

April 10, 2014

Record last verified: 2014-04

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01743638
Data provider: ClinicalTrials.gov
Source updated: 2014-04-10
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:23:36 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

MR-Guided Laser Ablation

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations